Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells.

Caballero S, Sengupta N, Afzal A, Chang KH, Li Calzi S, Guberski DL, Kern TS, Grant MB.

Diabetes. 2007 Apr;56(4):960-7.

2.

Circulating mononuclear progenitor cells: differential roles for subpopulations in repair of retinal vascular injury.

Caballero S, Hazra S, Bhatwadekar A, Li Calzi S, Paradiso LJ, Miller LP, Chang LJ, Kern TS, Grant MB.

Invest Ophthalmol Vis Sci. 2013 Apr 26;54(4):3000-9. doi: 10.1167/iovs.12-10280.

3.

Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice.

Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA.

J Clin Invest. 2000 Aug;106(4):571-8.

4.

Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells.

Jarajapu YP, Caballero S, Verma A, Nakagawa T, Lo MC, Li Q, Grant MB.

Invest Ophthalmol Vis Sci. 2011 Jul 7;52(8):5093-104. doi: 10.1167/iovs.10-70911.

5.

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A.

J Am Coll Cardiol. 2005 May 3;45(9):1449-57.

6.

Poor outcome of experimental ischemic stroke in type 2 diabetic rats: impaired circulating endothelial progenitor cells mobilization.

Yang H, Ma S, Liu Y, Li Y, Wu W, Han E, Jia G, Wang C.

J Stroke Cerebrovasc Dis. 2015 May;24(5):980-7. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.022. Epub 2015 Mar 23.

PMID:
25813059
7.

Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.

Kielczewski JL, Jarajapu YP, McFarland EL, Cai J, Afzal A, Li Calzi S, Chang KH, Lydic T, Shaw LC, Busik J, Hughes J, Cardounel AJ, Wilson K, Lyons TJ, Boulton ME, Mames RN, Chan-Ling T, Grant MB.

Circ Res. 2009 Oct 23;105(9):897-905. doi: 10.1161/CIRCRESAHA.109.199059. Epub 2009 Sep 17.

8.

Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy.

Tan K, Lessieur E, Cutler A, Nerone P, Vasanji A, Asosingh K, Erzurum S, Anand-Apte B.

Exp Eye Res. 2010 Aug;91(2):229-37. doi: 10.1016/j.exer.2010.05.012. Epub 2010 May 21.

9.

Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1.

Hazra S, Stepps V, Bhatwadekar AD, Caballero S, Boulton ME, Higgins PJ, Nikonova EV, Pepine CJ, Thut C, Finney EM, Stone DJ, Bartelmez SH, Grant MB.

PLoS One. 2013 Nov 1;8(11):e79067. doi: 10.1371/journal.pone.0079067. eCollection 2013.

10.

[In vivo evaluation of leukocyte dynamics in the retinal and choroidal circulation].

Ogura Y.

Nippon Ganka Gakkai Zasshi. 1999 Dec;103(12):910-22. Review. Japanese.

PMID:
10643293
11.

A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells.

Porat Y, Assa-Kunik E, Belkin M, Krakovsky M, Lamensdorf I, Duvdevani R, Sivak G, Niven MJ, Bulvik S.

Diabetes Metab Res Rev. 2014 Oct;30(7):623-34. doi: 10.1002/dmrr.2543.

PMID:
24638886
12.

Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.

Moriya J, Wu X, Zavala-Solorio J, Ross J, Liang XH, Ferrara N.

J Vasc Surg. 2014 May;59(5):1402-9.e1-4. doi: 10.1016/j.jvs.2013.04.053. Epub 2013 Jul 13.

13.

Synergistic targeting with bone marrow-derived cells and PDGF improves diabetic vascular function.

Klibansky DA, Chin A, Duignan IJ, Edelberg JM.

Am J Physiol Heart Circ Physiol. 2006 Apr;290(4):H1387-92. Epub 2005 Dec 9.

14.

Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes.

Kang L, Chen Q, Wang L, Gao L, Meng K, Chen J, Ferro A, Xu B.

Clin Exp Pharmacol Physiol. 2009 Oct;36(10):e47-56. doi: 10.1111/j.1440-1681.2009.05219.x. Epub 2009 Jun 16.

PMID:
19558529
15.

Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.

Tawfik A, Sanders T, Kahook K, Akeel S, Elmarakby A, Al-Shabrawey M.

Invest Ophthalmol Vis Sci. 2009 Feb;50(2):878-84. doi: 10.1167/iovs.08-2005. Epub 2008 Sep 20.

PMID:
18806296
16.

Diabetic eNOS-knockout mice develop accelerated retinopathy.

Li Q, Verma A, Han PY, Nakagawa T, Johnson RJ, Grant MB, Campbell-Thompson M, Jarajapu YP, Lei B, Hauswirth WW.

Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5240-6. doi: 10.1167/iovs.09-5147. Epub 2010 Apr 30.

17.

Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy.

Veenstra AA, Tang J, Kern TS.

PLoS One. 2013 Oct 21;8(10):e78405. doi: 10.1371/journal.pone.0078405. eCollection 2013.

18.

Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.

Bhatwadekar AD, Guerin EP, Jarajapu YP, Caballero S, Sheridan C, Kent D, Kennedy L, Lansang MC, Ruscetti FW, Pepine CJ, Higgins PJ, Bartelmez SH, Grant MB.

Diabetes. 2010 Aug;59(8):2010-9. doi: 10.2337/db10-0287. Epub 2010 May 11.

19.

Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N, Doerries C, Horváth T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, Landmesser U.

Circulation. 2007 Jul 10;116(2):163-73. Epub 2007 Jun 25.

PMID:
17592079
20.

Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.

Padilla E, Ganado P, Sanz M, Zeini M, Ruiz E, Triviño A, Ramírez AI, Salazar JJ, Ramírez JM, Rojas B, Hoz Rd, Tejerina T.

Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):132-42.

PMID:
15386814

Supplemental Content

Support Center